CVS Insider Trading
CVS HEALTH Corp | Retail-Drug Stores and Proprietary Stores
Comprehensive Trading Performance Summary
The investment history of corporate insiders at CVS HEALTH Corp provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Retail-Drug Stores and Proprietary Stores sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2010-08-11 23:00 | 2010-08-09 | Lofberg Per GH | Officer - President, Caremark Pharm Serv | BUY | $29.86 | 11,000 | $328,460 | 158,000 | +7.5% |
| 2010-03-18 23:01 | 2010-03-17 | Foulkes Helena | Officer - Senior Vice President | SELL | $34.93 | 7,000 | $244,510 | 863 | -89.0% |
| 2010-03-04 00:16 | 2010-03-02 | Finley Sara | Officer - SVP, Gen Counsel | OPT+S | $34.51 | 183,165 | $6,320,438 | 8,525 | 0.0% |
| 2010-02-19 23:43 | 2010-02-18 | Foulkes Helena | Officer - Senior Vice President | SELL | $34.00 | 12,280 | $417,520 | 8,406 | -59.4% |
| 2010-02-19 23:45 | 2010-02-17 | Lofberg Per GH | Officer - President, Caremark Pharm Serv | BUY | $34.10 | 147,000 | $5,012,582 | 147,000 | +100.0% |
| 2010-01-07 00:27 | 2010-01-04 | Lofberg Per GH | Officer - President, Caremark Pharm Serv | BUY | $32.98 | 45,483 | $1,500,029 | 45,483 | +100.0% |
| 2009-12-17 00:09 | 2009-12-14 | RICKARD DAVID B | Officer - Chief Financial Officer | OPT+S | $32.37 | 80,000 | $2,589,840 | 207,179 | 0.0% |
| 2009-11-13 22:33 | 2009-11-12 | WILLIAMS KRISTEN GIBNEY | Director | BUY | $30.00 | 1,000 | $29,998 | 63,408 | +1.6% |
| 2009-11-13 22:30 | 2009-11-11 | RYAN THOMAS M | Director, Officer - CEO & President | BUY | $29.96 | 17,000 | $509,342 | 638,025 | +2.7% |
| 2009-11-05 00:02 | 2009-11-02 | MCLURE HOWARD A | Officer - President, Caremark Pharm Serv | OPT+S | $35.71 | 100,000 | $3,570,960 | 0 | 0.0% |
| 2009-10-05 22:49 | 2009-10-01 | MCLURE HOWARD A | Officer - President, Caremark Pharm Serv | OPT+S | $35.64 | 100,000 | $3,563,560 | 0 | 0.0% |
| 2009-09-03 23:10 | 2009-09-01 | MCLURE HOWARD A | Officer - President, Caremark Pharm Serv | OPT+S | $37.45 | 100,000 | $3,744,650 | 0 | 0.0% |
| 2009-08-20 23:29 | 2009-08-18 | SGARRO DOUGLAS A | Officer - Executive Vice President | OPT+S | $34.51 | 381,226 | $13,155,118 | 169,728 | 0.0% |
| 2009-08-20 23:21 | 2009-08-19 | FERDINANDI V MICHAEL | Officer - Senior Vice President | SELL | $34.51 | 5,657 | $195,226 | 16,021 | -26.1% |
| 2009-08-19 23:08 | 2009-08-17 | RICKARD DAVID B | Officer - Chief Financial Officer | OPT+S | $33.96 | 251,520 | $8,540,865 | 207,179 | 0.0% |
| 2009-08-11 22:42 | 2009-08-07 | MCLURE HOWARD A | Officer - President, Caremark Pharm Serv | OPT+S | $34.25 | 200,000 | $6,850,620 | 0 | 0.0% |
| 2009-08-11 22:50 | 2009-08-07 | RYAN THOMAS M | Director, Officer - CEO & President | OPT+S | $34.41 | 400,000 | $13,763,120 | 752,081 | 0.0% |
| 2009-06-19 22:55 | 2009-06-17 | Roberts Jonathan C | Officer - Executive Vice President | OPT+S | $31.06 | 104,000 | $3,230,729 | 21,849 | 0.0% |
| 2009-06-19 22:51 | 2009-06-17 | MERLO LARRY J | Officer - Executive Vice President | OPT+S | $31.06 | 180,000 | $5,591,646 | 145,912 | 0.0% |
| 2009-05-14 22:42 | 2009-05-12 | WILLIAMS KRISTEN GIBNEY | Director | OPT+S | $32.85 | 127,431 | $4,186,223 | 59,711 | 0.0% |
| 2009-03-12 16:24 | 2009-03-10 | RYAN THOMAS M | Director, Officer - CEO & President | OPT+S | $25.05 | 1,700 | $42,585 | 714,426 | 0.0% |
| 2008-12-31 20:07 | 2008-12-29 | MCGUIGAN STUART M | Officer - SVP and CIO | BUY | $27.30 | 9,182 | $250,669 | 9,182 | +100.0% |
| 2008-11-18 23:53 | 2008-11-17 | Brennan Troyen A | Officer - Chief Medical Officer | BUY | $28.26 | 10,616 | $300,008 | 10,616 | +100.0% |
| 2008-09-11 23:54 | 2008-09-09 | SGARRO DOUGLAS A | Officer - Executive Vice President | OPT+S | $38.02 | 100,000 | $3,802,090 | 127,549 | 0.0% |
| 2008-05-28 23:48 | 2008-05-23 | FERDINANDI V MICHAEL | Officer - Senior Vice President | OPT+S | $42.35 | 139,080 | $5,890,483 | 4,049 | 0.0% |
| 2008-05-28 23:47 | 2008-05-23 | BODINE CHRIS W | Officer - Executive Vice President | OPT+S | $42.35 | 372,500 | $15,776,567 | 2,583 | 0.0% |
| 2008-03-07 23:37 | 2008-03-05 | Denton David M | Officer - Controller | BUY | $40.23 | 1,242 | $49,966 | 12,369 | +11.2% |
| 2008-02-22 00:34 | 2008-02-19 | RYAN THOMAS M | Director, Officer - CEO & President | OPT+S | $40.01 | 1,200,000 | $48,011,280 | 631,549 | 0.0% |
| 2008-02-13 00:31 | 2008-02-11 | PICCOLO C A | Director | OPT+S | $39.83 | 140,549 | $5,598,587 | 169,025 | 0.0% |
| 2008-02-12 00:15 | 2008-02-07 | MCLURE HOWARD A | Officer - President, Caremark Pharm Serv | OPT+S | $39.73 | 350,000 | $13,904,800 | 11,379 | 0.0% |
| 2007-11-21 01:08 | 2007-11-16 | FERDINANDI V MICHAEL | Officer - Senior Vice President | OPT+S | $42.05 | 88,780 | $3,732,755 | 4,049 | 0.0% |
| 2007-11-16 00:30 | 2007-11-14 | MILLON JEAN PIERRE | Director | OPT+S | $42.28 | 28,364 | $1,199,289 | 8,617 | 0.0% |
| 2007-09-05 00:14 | 2007-08-30 | Roberts Jonathan C | Officer - SVP and CIO | OPT+S | $37.58 | 107,020 | $4,021,940 | 16,105 | 0.0% |
| 2007-09-05 00:15 | 2007-08-31 | CRAWFORD EDWIN M | Director, Officer - Chairman | OPT+S | $37.83 | 1,200,000 | $45,399,120 | 135,498 | 0.0% |
| 2007-09-05 00:12 | 2007-08-31 | BROWN C DAVID II | Director | OPT+S | $37.75 | 163,751 | $6,181,617 | 0 | 0.0% |
| 2007-09-05 00:19 | 2007-08-30 | BODINE CHRIS W | Officer - Executive Vice President | OPT+S | $37.61 | 77,512 | $2,915,412 | 2,323 | 0.0% |
| 2007-08-16 23:12 | 2007-08-14 | RYAN THOMAS M | Director, Officer - CEO & President | OPT+S | $37.53 | 391,320 | $14,684,518 | 452,473 | 0.0% |
| 2007-08-09 23:12 | 2007-08-07 | MERLO LARRY J | Officer - Executive Vice President | OPT+S | $37.46 | 330,440 | $12,379,142 | 134,267 | 0.0% |
| 2007-06-19 23:29 | 2007-06-18 | Spalding William R | Officer - EVP Caremark Pharmacy Services | OPT+S | $37.35 | 250,000 | $9,337,675 | 182 | 0.0% |
| 2007-06-19 23:28 | 2007-06-18 | BANKS EDWIN M | Director | SELL | $37.30 | 24,194 | $902,378 | 18,797 | -56.3% |
| 2007-06-12 23:49 | 2007-06-11 | MCLURE HOWARD A | Officer - President, Caremark Pharm Serv | OPT+S | $37.51 | 610,000 | $22,878,416 | 0 | 0.0% |
| 2007-06-12 23:49 | 2007-06-11 | WILLIAMS KRISTEN GIBNEY | Director | OPT+S | $37.51 | 33,739 | $1,265,526 | 46,747 | 0.0% |
| 2007-06-12 23:49 | 2007-06-11 | RICKARD DAVID B | Officer - Chief Financial Officer | OPT+S | $37.49 | 197,652 | $7,410,369 | 205,681 | 0.0% |
| 2007-06-12 23:49 | 2007-06-11 | FERDINANDI V MICHAEL | Officer - Senior Vice President | OPT+S | $37.49 | 132,600 | $4,971,041 | 4,049 | 0.0% |
| 2007-06-12 23:48 | 2007-06-11 | BODINE CHRIS W | Officer - Executive Vice President | OPT+S | $37.50 | 17,400 | $652,500 | 2,323 | 0.0% |
| 2007-05-24 22:15 | 2007-05-23 | HEADRICK ROGER L | Director | BUY | $38.01 | 6,495 | $246,896 | 2,200 | +100.0% |
| 2007-05-14 23:13 | 2007-05-11 | SGARRO DOUGLAS A | Officer - Executive Vice President | OPT+S | $37.49 | 140,460 | $5,266,506 | 112,246 | 0.0% |
| 2007-05-14 23:14 | 2007-05-11 | MILLON JEAN PIERRE | Director | SELL | $37.30 | 8,946 | $333,686 | 7,586 | -54.1% |
| 2006-12-20 00:41 | 2006-12-15 | RYAN THOMAS M | Director, Officer - Chairman, CEO & President | OPT+S | $30.26 | 156,600 | $4,738,199 | 362,446 | 0.0% |
| 2006-12-15 23:55 | 2006-12-13 | RYAN THOMAS M | Director, Officer - Chairman, CEO & President | OPT+S | $30.52 | 104,400 | $3,186,372 | 284,254 | 0.0% |
How to Interpret $CVS Trades
Not every insider transaction in CVS HEALTH Corp is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CVS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for CVS
Insider activity data for CVS HEALTH Corp is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CVS, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.